✦ LIBER ✦

Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: A population-based cohort study in Italy

✍ Scribed by Cammarota, S.; Bruzzese, D.; Catapano, A.L.; Citarella, A.; De Luca, L.; Manzoli, L.; Masulli, M.; Menditto, E.; Mezzetti, A.; Riegler, S.; Putignano, D.; Tragni, E.; Novellino, E.; Riccardi, G.

Book ID: 122313186
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 632 KB
Volume: 24
Category: Article
ISSN: 0939-4753
DOI: 10.1016/j.numecd.2013.04.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of cancer in patients on insulin gl

Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study

✍ R. Ruiter; L. E. Visser; M. P. P. van Herk-Sukel; J. W. W. Coebergh; H. R. Haak; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 279 KB

Request for clarification from Ruiter et

Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’

✍ B. Carstensen 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 69 KB

Request for clarification from Ruiter et

✍ R. Ruiter; L. E. Visser; B. H. Ch. Stricker 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 72 KB

Response to Comment on: Bergenstal et al

Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140-2147

✍ Bergenstal, R. M.; Rosenstock, J.; Arakaki, R. F.; Prince, M. J.; Qu, Y.; Sinha, 📂 Article 📅 2013 🏛 American Diabetes Association 🌐 English ⚖ 48 KB

PDB11 A Large-Scale Longitudinal Populat

PDB11 A Large-Scale Longitudinal Population-Based Study of Risk Reduction of Cardiovascular Complications in Patients on Bolus Insulin Analogues

✍ Cammarota, S.; Bruzzese, D.; Catapano, A.L.; Citarella, A.; De luca, L.; Manzoli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PDB54 COMPARISON OF TREATMENT COSTS BETW

PDB54 COMPARISON OF TREATMENT COSTS BETWEEN BASAL-SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE (GLA) AND BOT WITH INSULIN DETEMIR (DET) IN PATIENTS WITH TYPE 2 DIABETES (T2D): ECONOMIC EVALUATION BASED ON THE RESULTS OF THE INSULIN GLARGINE (LANTUS®) VERSUS INSULIN DETEMIR (LEVEMIR®) TREAT-TO-TARGET (L2T3) STUDY

✍ PK Schädlich; KC Koltermann; FW Dippel; EG Hagenmeyer; B Häussler 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB